Preparation of radioiodinated ritodrine as a potential agent for lung imaging |
| |
Authors: | H M Rashed I T Ibrahim M A Motaleb A Abd El-Bary |
| |
Institution: | 1. Labeled Compound Department, Hot Laboratory Center, Atomic Energy Authority, P.O. 13759, Cairo, Egypt 2. Pharmaceutics Department, Faculty of Pharmacy, Cairo University, Giza, Egypt
|
| |
Abstract: | Ritodrine (a beta-2 adrenergic receptor agonist) was successfully labeled with 125I via direct electrophilic substitution reaction at ambient temperature. 125I-ritodrine was obtained with a maximum labeling yield of 97 ± 0.163 % and in vitro stability up to 24 h. Biodistribution studies showed that maximum in vivo uptake of 125I-ritodrine in lungs was 20.4 ± 0.22 % injected activity/g tissue at 1 h post-injection, whereas the clearance from mice appeared to proceed mainly via the renal pathway. 125I-ritodrine is not a blood product and so it is more safe than the currently available 99mTc-MAA, and its lung uptake is higher than that of the recently discovered 99mTc(CO)5I and 99mTc-DHPM. As a conclusion, radioiodinated ritodrine could be used as a novel radiopharmaceutical for lung perfusion scan safer than the currently available 99mTc-MAA and more potential than the recently discovered 99mTc(CO)5I and 99mTc-DHPM. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|